Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of GSI Technology Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation Details - The investigation is prompted by a post on Stockwits claiming that GSI Technology may be concealing that their chip did not run the Gemma-3 but only the pre-generation RAG phase, and that their APU lacks the necessary MAC units for critical AI workloads [3]. - Rosen Law Firm is preparing a class action to seek recovery of investor losses, indicating that affected investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone, and has consistently ranked in the top 4 for securities class action settlements since 2013 [3].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Picard Medical, Inc. due to allegations of securities law violations, encouraging affected investors to come forward [2][4]. Group 1: Legal Investigation and Claims - The law firm is reminding investors of the April 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action against Picard Medical [2]. - Allegations against Picard Medical include involvement in a fraudulent stock promotion scheme and misleading public statements regarding the company's financial health [4]. Group 2: Stock Performance and Impact - On October 24, 2025, Picard Medical's shares closed at $5.31, a significant drop from $13.20 on October 23, 2025, representing a decline of $7.89 per share or approximately 59.8% in a single trading session [5]. Group 3: Firm Background - Faruqi & Faruqi, LLP has recovered hundreds of millions of dollars for investors since its establishment in 1995, with offices in New York, Pennsylvania, California, and Georgia [3].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of PennyMac Financial Services, Inc. due to allegations of materially misleading business information issued to the investing public [1]. Group 1: Legal Action and Investor Rights - Investors who purchased PennyMac securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees, as the Rosen Law Firm is preparing to seek recovery of investor losses [2]. - Interested investors can join the prospective class action by submitting a form or contacting the firm directly [2]. Group 2: Financial Performance and Stock Impact - On January 29, 2026, PennyMac reported its fourth quarter and full-year 2025 financial results, revealing a significant decline in pretax income for its servicing segment, which was $37.3 million, down from $157.4 million in the prior quarter and $87.3 million in the same quarter of the previous year [3]. - The report indicated that pretax income excluding valuation-related items was $47.8 million, reflecting a 70% decrease from the prior quarter, primarily due to increased realization of mortgage servicing rights cash flows as lower mortgage rates led to higher prepayment activity [3]. - Following the financial report, PennyMac's stock price dropped by $49.78 per share, or 33.3%, closing at $99.92 per share on January 30, 2026 [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has consistently ranked in the top 4 for securities class action settlements since 2013 and has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - The complaint against Klarna alleges that the company and its executives violated federal securities laws by making false or misleading statements regarding the risk of loss reserves increasing shortly after the IPO, leading to investor damages when the true information became public [2]. Group 1 - The lawsuit claims that Klarna materially understated the risk associated with its buy now, pay later (BNPL) loans, which they either knew or should have known [2]. - Defendants' public statements were deemed materially false and misleading at all relevant times, and were negligently prepared [2]. - Investors suffered damages when the true details about Klarna's financial situation were revealed to the market [2]. Group 2 - The lead plaintiff in the class action is the investor with the largest financial interest in the relief sought, who will oversee the litigation on behalf of the class [3]. - Any member of the putative class can move the court to serve as lead plaintiff or choose to remain an absent class member without affecting their ability to share in any recovery [3]. Group 3 - Faruqi & Faruqi, LLP encourages individuals with information regarding Klarna's conduct to come forward, including whistleblowers and former employees [4].

Core Viewpoint - The complaint against the Company alleges violations of federal securities laws due to false and misleading statements regarding mining activities at the Brook Mine, indicating that no significant work has commenced despite prior claims [2]. Group 1: Allegations of Misconduct - The Company and its executives are accused of not commencing any significant mining activity at the Brook Mine after groundbreaking [2]. - It is claimed that no active work is taking place at the Brook Mine, leading to an overstatement of development progress [2]. - The positive statements made by the Defendants about the Company's business, operations, and prospects are described as materially misleading and lacking a reasonable basis [2]. Group 2: Legal Proceedings - The court-appointed lead plaintiff is identified as the investor with the largest financial interest in the relief sought by the class, who will oversee the litigation on behalf of the class members [3]. - Any member of the putative class has the option to move the Court to serve as lead plaintiff or remain an absent class member without affecting their ability to share in any recovery [3]. Group 3: Whistleblower Encouragement - The law firm Faruqi & Faruqi encourages individuals with information regarding Ramaco's conduct to come forward, including whistleblowers, former employees, and shareholders [4].

Core Viewpoint - The complaint against Ultragenyx alleges violations of federal securities laws due to misleading statements regarding the efficacy of setrusumab in treating Osteogenesis Imperfecta, particularly concerning the Phase III Orbit study results and the associated risks [2]. Group 1: Allegations and Misleading Information - The complaint claims that Ultragenyx and its executives created a false impression of having reliable information about setrusumab's effects on patients with Osteogenesis Imperfecta [2]. - It is alleged that Ultragenyx downplayed the risk that patients in the Phase III Orbit study would not achieve a statistically significant reduction in annualized fracture rate, which is critical for the study's interim analysis [2]. - The optimism expressed by Ultragenyx regarding the Phase III Orbit study's results is said to be misplaced, as the company failed to adequately disclose the risks associated with relying on Phase II results that lacked a placebo control group [2]. Group 2: Legal Proceedings and Class Action - The lead plaintiff in the class action is the investor with the largest financial interest in the relief sought, who will oversee the litigation on behalf of the class [3]. - Any member of the putative class has the option to move the court to serve as lead plaintiff or remain an absent class member without affecting their ability to share in any recovery [3]. Group 3: Whistleblower Encouragement - The law firm Faruqi & Faruqi encourages individuals with information regarding Ultragenyx's conduct, including whistleblowers and former employees, to come forward [4].

Core Viewpoint - The complaint against Mereo BioPharma alleges violations of federal securities laws due to false or misleading statements regarding the Phase 3 ORBIT and COSMIC programs, which failed to meet their primary endpoints in reducing annualized clinical fracture rates compared to control groups [2] Group 1: Legal Proceedings - The lead plaintiff in the class action is the investor with the largest financial interest in the relief sought and is representative of the class members [3] - Any member of the putative class can move the Court to serve as lead plaintiff or choose to remain an absent class member without affecting their ability to share in any recovery [3] Group 2: Whistleblower Information - The law firm encourages individuals with information regarding Mereo BioPharma's conduct, including whistleblowers and former employees, to come forward [4]

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Plug Power Inc. securities during the specified Class Period, indicating potential legal issues surrounding the company's disclosures and financial statements [1]. Group 1: Lawsuit Details - The class action lawsuit pertains to securities purchased between January 17, 2025, and November 13, 2025, and aims to address alleged misleading statements made by Plug Power regarding funding from the U.S. Department of Energy [1][5]. - The lawsuit claims that Plug Power overstated the likelihood of receiving funds from the Department of Energy and misrepresented its ability to construct necessary hydrogen production facilities, leading to potential damages for investors [5]. Group 2: Participation Information - Investors who purchased Plug Power securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors, with notable achievements in 2019 and 2020 [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Phoenix Education Partners, Inc. due to allegations of materially misleading business information issued to the public [1] Group 1: Legal Action and Investor Rights - Investors who purchased Phoenix Education securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2] - The Rosen Law Firm is preparing a class action to seek recovery of investor losses [2] Group 2: Data Breach Incident - A significant data breach at the University of Phoenix has affected nearly 3.5 million individuals, with the breach traced back to August 2025 [3] - The breach involved unauthorized access to the university's network, resulting in the theft of sensitive information [3] Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [3] - The firm has been ranked No. 1 for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [3] - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [3]

Core Viewpoint - Coupang, Inc. is facing a class action lawsuit due to allegations of misleading investors regarding its cybersecurity measures, particularly related to a significant data breach affecting 33.7 million accounts, which went undetected for nearly six months [2][7]. Group 1: Allegations and Impact - The lawsuit claims that Coupang misrepresented its "proactive security" and "administrative safeguards" while failing to detect a data breach that allowed a former employee to access sensitive customer information [2][7]. - The breach has resulted in a compensation plan of approximately $1.2 billion (1.685 trillion won) and the resignation of CEO Park Dae-joon, leading to a loss of over $8 billion in market value [2][7]. - Coupang acknowledged awareness of the cybersecurity incident on November 18, 2025, just 11 days before public disclosure, indicating a significant delay in informing stakeholders [7]. Group 2: Investigation and Legal Proceedings - Hagens Berman, a shareholder rights firm, is investigating the claims and has set a lead plaintiff deadline of February 17, 2026, for investors who suffered losses during the class period from May 7, 2025, to December 16, 2025 [1][5]. - The investigation focuses on Coupang's alleged failure to maintain adequate internal controls that allowed unauthorized access to customer accounts [7]. - The firm is encouraging affected investors to contact them for potential participation in the lawsuit [1][5].